Mikhail Oskarovich Varshavski, MD, also known as "Doctor Mike," has spent the last quarter-century pushing back against ...

Based on sessions presented at CHEST 2026, tirzepatide and semaglutide demonstrate significant clinical benefits in obesity ...

Interstitial lung disease and obstructive sleep apnea share a bidirectional pathophysiology that may complicate screening and ...

The CHEST 2026 Annual Meeting will take place October 18 to 21 in Phoenix, Arizona and will feature more than 300 educational ...

Ashley Drapeau shared her insights on integrating holistic and Western medicine to treat patients with long COVID and the value of self-care as a PA. In celebration of PA Week, The Clinical Advisor ...

Glucagon-like peptide-1 receptor agonists improve obstructive sleep apnea outcomes in obesity, primarily through significant weight loss.

In patients with pulmonary hypertension, measures of pulmonary artery stiffness and RV function may be significant predictors of mortality.

Aggregate surgeon supply is projected to decline to 2038, resulting in a national workforce adequacy of 83.4%.

A novel machine learning model accurately screened for psychologic distress in patients with chronic rhinosinusitis using routine clinical variables.

Electronic cigarette and household tobacco use are associated with worse parent-reported asthma control among children with asthma.

In the United Kingdom, 2.9% of patients undergoing anesthesia reported receiving glucagon-like peptide-1 receptor agonists.